title: Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.
authors.affiliation: School of Chemistry, The University of Sydney, New South Wales 2006, Australia.
authors.forename: Brendan L
authors.initials: BL
authors.lastname: Wilkinson
authors.forename: Stephanie
authors.initials: S
authors.lastname: Day
authors.forename: Lara R
authors.initials: LR
authors.lastname: Malins
authors.forename: Vasso
authors.initials: V
authors.lastname: Apostolopoulos
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Payne
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry; D000595:Amino Acid Sequence; D000818:Animals; D019496:Cancer Vaccines / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology; D045744:Cell Line, Tumor; D004151:Dipeptides / Q000737:chemistry* / Q000276:immunology; D006031:Glycosylation; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008074:Lipoproteins / Q000737:chemistry* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D018396:Mucin-1 / Q000737:chemistry* / Q000276:immunology; D051195:Toll-Like Receptor 2 / Q000819:agonists* / Q000378:metabolism
chemical_list: D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D004151:Dipeptides; D007074:Immunoglobulin G; D008074:Lipoproteins; D018396:Mucin-1; D051195:Toll-Like Receptor 2; C047210:2,3-bis-(palmitoyloxy)-2-propyl-N-palmitoyl-cysteinylserine